|
BHC | Bausch Health Companies Inc. |
|
|
BHC | Bausch Health Companies Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.32 |
| Leverage | 103.23% |
| Market Cap | $ 2.5B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -1.1B |
| Margin | -10.17% |
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.